Background: Late-onset Alzheimer's disease (LOAD) is the most common form of 31 dementia worldwide. To date, animal models of Alzheimer's have focused on rare 32 familial mutations, due to a lack of frank neuropathology from models based on 33 common disease genes. Recent multi-cohort studies of postmortem human brain 34 transcriptomes have identified a set of 30 gene co-expression modules associated with 35 LOAD, providing a molecular catalog of relevant endophenotypes. Results: This 36 resource enables precise gene-based alignment between new animal models and 37 human molecular signatures of disease. Here, we describe a new resource to efficiently 38 screen mouse models for LOAD relevance. A new NanoString nCounter® Mouse AD 39 panel was designed to correlate key human disease processes and pathways with 40 mRNA from mouse brains. Analysis of three mouse models based on LOAD genetics, 41 carrying APOE4 and TREM2*R47H alleles, demonstrated overlaps with distinct human 42 AD modules that, in turn, are functionally enriched in key disease-associated pathways. 43 Comprehensive comparison with full transcriptome data from same-sample RNA-Seq 44 shows strong correlation between gene expression changes independent of 45 experimental platform. Conclusions: Taken together, we show that the nCounter 46 Mouse AD panel offers a rapid, cost-effective and highly reproducible approach to 47 assess disease relevance of potential LOAD mouse models.
genes on the Mouse AD panel also displayed a higher average level of gene expression 144 in brains of six-month-old B6 mice compared to the remaining genes for each of the 30 145 modules (Figure 3 ). This highlights that our formal prioritization procedure resulted in 146 the selection of a subset of highly expressed key genes, which are also more conserved 147 between human and mouse facilitating the translation of co-expression profiles across 148 species. 149 Novel mouse models harboring LOAD associated risk variants correlate with distinct 150 AMP-AD modules in a brain region-and pathway-specific manner 151 Three novel mouse models, harboring two LOAD risk alleles, ( Supplemental Table S4 ) 152 were used to translate co-expression profiles between human and mouse brain 153 transcriptome data using our novel Mouse AD panel. Transcriptome analysis was 154 performed for the APOE4 KI mouse, carrying a humanized version of the strongest 155 LOAD associated risk allele (APOE-ε4) and the Trem2*R47H mouse, which harbors a 156 rare deleterious variant in TREM2. The rare TREM2 R47H missense variant (p-value < 0.05, Pearson's correlation coefficient < -0.3) with human co-expression 167 modules in Consensus Cluster E that are enriched for transcripts associated with cell 168 cycle and RNA non-mediated decay pathways in multiple brain regions ( Figure 4 ).
169
Furthermore, Trem2*R47H male mice showed a significantly negative association (p- Figure 5B) . Notably, we observed an age specific effect in which the correlation 207 between nCounter probe expression and RNA-Seq transcripts increased over time 208 ( Figure 5B) . A mild correlation at around three months of age (Pearson's correlation 209 coefficient: 0.39) increased to a moderate correlation at 12 months of age (Pearson's 210 correlation coefficient: 0.51). Furthermore, we observed a high correlation of log count 211 values for the majority of NanoString probes when compared to log TPM transcript ratios from RNA-Seq data. The majority of the 770 measured NanoString probes 213 (716/770 probes, 93%) were positively correlated with RNA-Seq transcripts ( Figure S2 ).
214
In order to test whether noise introduced by highly variable transcripts affects the 215 correlation between NanoString probes and RNA-Seq transcripts, Pearson's correlation 216 coefficients and variance in RNA-Seq expression across 137 samples were compared.
217
There was no significant trend indicating an effect of highly variable transcripts on the 218 overall correlation coefficients between transcripts measured by RNA-Seq and 219 NanoString ( Figure S2 ).
220

DISCUSSION
221
Here, we describe a novel systems biology approach to rapidly assess disease 222 relevance for three novel mouse models carrying two human risk variants, strongly separately using fixed/mixed effects modeling to account for batch effects. Among the Human-mouse sequence divergence (median dN/dS values) is inversely correlated (Pearson's correlation coefficient: -0.96) with the fraction of genes being expressed in B6 mouse brain for each of the human co-expression modules. (B) Coverage of the 770 selected mouse NanoString probes for the 30 human co-expression modules associated with five functional consensus clusters. The size and number of human coexpression modules differs for the three post-mortem brain cohorts (ROSMAP, Mayo, Mount Sinai Brain Bank) and across the seven included brain regions. (C) This results in a varying degree of probe coverage for each module with a number of disease associated consensus clusters (A-E), reflecting disease related pathways and processes.
Figure 3: NanoString Mouse AD probe genes are more conserved and have greater expression in the mouse brain
Comparison between gene-level sequence divergence and transcript abundances in six month old B6 mouse brains for all genes (red) and the subset of 770 genes covered by NanoString probes (green).
Figure 4: Correlations between mouse model effects and LOAD effects for the NanoString Mouse AD panel genes across 30 human co-expression modules
Circles correspond to significant (p-value < 0.05) positive (blue) and negative (red) Pearson's correlation coefficients for gene expression changes in mice (log fold change of strain minus age-matched B6 mice) and human disease (log fold change for cases minus controls). Human co-expression modules are ordered into Consensus Clusters A-E (12) describing major sources of AD-related alterations in transcriptional states across independent studies and brain regions. Consensus clusters are annotated based on the most significantly enriched and non-redundant Reactome pathway terms (Supplemental Tables S1, S2).
Figure 5: Platform comparison between the nCounter Mouse AD panel and RNA-Seq correlation with AMP-AD modules across 137 samples
The plots display the correlation between human AMP-AD co-expression modules and gene expression profiles derived from the NanoString panel and RNA-Seq data for the same 137 mouse samples. A detailed comparison is provided for three different age stages and three mouse models carrying LOAD associated risk variants. (A) A strong positive correlation was observed across all ages and samples combined when comparing expression of the 770 transcripts on the NanoString panel. (B) The correlation between NanoString and RNA-Seq expression analysis decreased overall when comparing all module transcripts measured by RNA-Seq to the subset of 770 probes on the NanoString panel. However, an age specific effect was observed for the mouse transcripts in which correlation with human co-expression modules increased with age.
